Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Sirona Biochem's shares outstanding for the quarter that ended in Jul. 2024 was 258.84 Mil.
Sirona Biochem's quarterly shares outstanding
increased
from Apr. 2024 (256.46 Mil) to Jul. 2024 (258.84 Mil).
It means Sirona Biochemissued new shares from Apr. 2024 to Jul. 2024 .
Sirona Biochem's annual shares outstanding
increased
from Oct. 2022 (251.73 Mil) to Oct. 2023 (253.61 Mil).
It means Sirona Biochemissued new shares from Oct. 2022 to Oct. 2023 .
A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.
Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.
Be Aware
Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.
Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.
If net earnings is less than 10%, likely to be in a highly competitive business.
Sirona Biochem Shares Outstanding (EOP) Related Terms
Sirona Biochem Shares Outstanding (EOP) Historical Data
* Premium members only.
The historical data trend for Sirona Biochem's Shares Outstanding (EOP) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:ZSB vs MTNB, TCRT, QLGN: Shares Outstanding (EOP) Comparison
For the Biotechnology subindustry, Sirona Biochem's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sirona Biochem Shares Outstanding (EOP) vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sirona Biochem's Shares Outstanding (EOP) distribution charts can be found below:
* The bar in red indicates where Sirona Biochem's Shares Outstanding (EOP) falls into.
Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.
Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.
What does a Shares Outstanding (EOP) of 258.84 Mil mean?
Sirona Biochem (STU:ZSB) has a Shares Outstanding (EOP) of 258.84 Mil as of Jul. 2024. The total shares a company has outstanding, at period-end. View historical data on Sirona Biochem and its competitors.
Is Sirona Biochem's Shares Outstanding (EOP) too high?
Sirona Biochem's current Shares Outstanding (EOP) is 258.84 Mil.
How does Sirona Biochem's Shares Outstanding (EOP) compare to MTNB and TCRT?
Sirona Biochem's Shares Outstanding (EOP) of 258.84 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Biotechnology company?
A good Shares Outstanding (EOP) depends on the Biotechnology industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Sirona Biochem and its competitors. Sirona Biochem's current Shares Outstanding (EOP) is 258.84 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sirona Biochem stock overvalued right now?
Sirona Biochem (STU:ZSB) has a current Shares Outstanding (EOP) of 258.84 Mil. The current Shares Outstanding (EOP) is 258.84 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Sirona Biochem (STU:ZSB), the current Shares Outstanding (EOP) is 258.84 Mil as of Jul. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. The company has a business presence in Canada and France.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:ZSB has been successfully added to your 
